Table 1.

Randomized phase III antiangiogenic therapy trials

Abbreviations: COOP, Group conducting study; if blank, the study is conducted by the drug manufacturer; CPB, Child-Pugh B; CSF-1R, colony-stimulating factor 1 receptor; EGFR, epidermal growth factor receptor; FGFR, fibroblast growth factor receptor; NCT, National Clinical Trial; PDGFR, platelet-derived growth factor receptor; RET, rearranged during transfection (receptor kinase); RFA, radio frequency ablation; TACE, transcatheter arterial chemoembolization; VEGFR, vascular endothelial growth factor receptor.